Aytu BioScience

AYTU54

Penny Stock

$1.77arrow_drop_up7.92%$0.13

Penny Stock

AYTU54

$1.77

arrow_drop_up7.92%$0.13

Penny Stock

Performance History

Key Stats
Open	$1.74
Prev. Close	$1.64
EPS	-2.86
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$11.00M
PE Ratio	-

	LOW	HIGH
Day Range	1.70	2.25
52 Week Range	1.61	3.50

Ratios

Revenue	-





EPS	-2.86

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Aytu BioScience (AYTU)

Aytu BioScience Inc (AYTU) is a pharmaceutical company that specializes in the development and commercialization of novel therapeutics and diagnostic products. The company is focused on addressing unmet medical needs in the areas of urology and infectious diseases. Aytu BioScience aims to improve patient outcomes and deliver innovative solutions to healthcare providers and patients worldwide.

The stock price history of Aytu BioScience Inc (AYTU) shows a volatile but upward trend. In recent years, the stock has experienced significant fluctuations, reflecting the company's performance and market conditions. Investors should carefully consider the risks and potential rewards before making investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. Joshua R. Disbrow
Headquarters: Englewood
Employees: 164
Exchange: NASDAQ

Keep an eye on Aytu BioScience

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Aytu BioScience 's (AYTU) price per share?

The current price per share for Aytu BioScience (AYTU) is $1.77. The stock has seen a price change of $0.13 recently, indicating a 7.93% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Aytu BioScience (AYTU)?

For Aytu BioScience (AYTU), the 52-week high is $3.5, which is 97.74% from the current price. The 52-week low is $1.61, the current price is 9.94% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Aytu BioScience (AYTU) a growth stock?

Aytu BioScience (AYTU) has shown an average price growth of -2.31% over the past three years. It has received a score of 2 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Aytu BioScience as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Aytu BioScience (AYTU) stock price performance year to date (YTD)?

As of the latest data, Aytu BioScience (AYTU) has a year-to-date price change of -38.75%. Over the past month, the stock has experienced a price change of -20.98%. Over the last three months, the change has been -25.32%. Over the past six months, the figure is -47.16%. Looking at a longer horizon, the five-year price change stands at -99.12%.

help

Is Aytu BioScience (AYTU) a profitable company?

Aytu BioScience (AYTU) has a net income of -$15.84M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 67.39% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -4.45% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $54.59M. Operating income is noted at -$5.25M. Furthermore, the EBITDA is $5.95M.

help

What is the market capitalization of Aytu BioScience (AYTU)?

Aytu BioScience (AYTU) has a market capitalization of $10.88M. The average daily trading volume is 1.79, indicating the stock's liquidity and investor engagement.